Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 4, 2010, Pages 2024-2034

  Panagis, Lampros ^a   Zhao, Xiujun ^a   Ge, Yongchao ^a   Ren, Lizhen ^a   Mittag, Thomas W ^a   Danias, John ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; FLUOROGOLD; SCLEROPROTEIN; 2 HYDROXY 4,4' DIAMIDINOSTILBENE, METHANESULFONATE SALT; 2-HYDROXY-4,4'-DIAMIDINOSTILBENE, METHANESULFONATE SALT; CARRIER PROTEIN; ENZYME; HLA ANTIGEN CLASS 2; STILBAMIDINE;

ABCE1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXA2 GENE; ARIH1 GENE; ARTICLE; ATP6V0D1 GENE; CALD1 GENE; CELL LABELING; CELL LOSS; CONTROLLED STUDY; CTNNA1 GENE; CUL5 GENE; DBA 2 MOUSE; DNA MICROARRAY; DOWN REGULATION; EDN2 GENE; EGLN1 GENE; FARSLA GENE; FEMALE; FOXN2 GENE; FSTL5 GENE; FYTTD1 GENE; FZD1 GENE; GENE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GLAUCOMA; GLS GENE; GPSN2 GENE; IGF2BP2 GENE; IMMUNE RESPONSE; IMMUNOBLOTTING; KCNMA1 GENE; LXN GENE; MCL1 GENE; MICROARRAY ANALYSIS; MOUSE; MTHFD2 GENE; MYOLB GENE; NISCH GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OCR1 GENE; OCRL GENE; OPA1 GENE; OSBP19 GENE; PATHOPHYSIOLOGY; PBX1 GENE; POLB GENE; POLR3F GENE; PPP2R52 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PSMD14 GENE; RAB37 GENE; RBM18 GENE; RETINA GANGLION CELL; RETINA PRESERVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RGS10 GENE; RPGRIP1 GENE; SBF2 GENE; SH2BP1 GENE; SLC17A6 GENE; SNTB2 GENE; SPIN2 GENE; STK22S1 GENE; TATDN1 GENE; TBC1D23 GENE; TBC1D5 GENE; TBRG3 GENE; TISSUE PRESERVATION; TRIM24 GENE; TXNRD3 GENE; UNINDEXED SEQUENCE; UPREGULATION; WDR26 GENE; WWP1 GENE; ZFP292 GENE; ZFP318 GENE; ANIMAL; DBA MOUSE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; OPEN ANGLE GLAUCOMA; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; ENZYMES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLAUCOMA, OPEN-ANGLE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOBLOTTING; MICE; MICE, INBRED DBA; MICROARRAY ANALYSIS; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBAMIDINES; UP-REGULATION;

EID: 77951248779     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3560     Document Type: Article

References (62)

1. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
2. Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44:4314-4320.
3. Ruiz-Ederra J, Verkman AS. Mouse model of sustained elevation in intraocular pressure produced by episcleral vein occlusion. Exp Eye Res. 2006;82:879-884.
4. Sheldon WG, Warbritton AR, Bucci TJ, Turturro, A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508-518.
5. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2002;30:81-85.
6. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci. 2003;44:5151-5162.
7. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells, RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
8. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313-325.
9. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585-1592.
10. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol. 2005;12: 882-893.
11. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
12. Anderson MG, Libby RT, Gould DB, Smith RS, John SW. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci U S A. 2005;102: 4566-4571.
13. Filippopoulos T, Danias J, Chen B, Podos SM, Mittag TW. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest Ophthalmol Vis Sci. 2006;47:1968-1974.
14. Kurian KM, Watson CJ, Wyllie AH. DNA chip technology. J Pathol. 1999;187:267-271.
15. Bednar M. DNA microarray technology and application. Med Sci Monit. 2000;6:796-800.
16. Hofman P. DNA microarrays. Nephron Physiol. 2005;99:85-89.
17. Chen JJ, Hsueh HM, Delongchamp RR, Lin CJ, Tsai, CA. Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data. BMC Bioinformatics. 2007;8:412.
18. Hernandez MR, Agapova OA, Yang P, Salvador-Silva M, Ricard CS, Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia. 2002;38:45-64.
19. Ishibashi T, Takagi Y, Mori K, et al. cDNA microarray analysis of gene expression changes induced by dexamethasone in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sc.i 2002;43:3691-3697.
20. Yoshimura N. Retinal neuronal cell death: molecular mechanism and neuroprotection (in Japanese). Nippon Ganka Gakkai Zasshi. 2001;105:884-902.
21. Piri N, Kwong JM, Song M, Elashoff D, Caprioli J. Gene expression changes in the retina following optic nerve transection. Mol Vis. 2006;12:1660-1673.
22. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
23. Miyahara T, Kikuchi T, Akimoto M, Kurokawa T, Shibuki H, Yoshimura N. Gene microarray analysis of experimental glaucomatous retina from cynomolgus monkey. Invest Ophthalmol Vis Sci. 2003;44:4347-4356.
24. Miao H, Chen L, Riordan SM, et al. Gene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors. PLoS ONE. 2008;3:e2847.
25. Etienne W, Meyer MH, Peppers J, Meyer RA Jr. Comparison of mRNA gene expression by RT-PCR and DNA microarray. BioTechniques. 2004;36:618-620,622,624-626.
26. Jiang B, Brown JL, Sheraton J, Fortin N, Bussey H. A new family of yeast genes implicated in ergosterol synthesis is related to the human oxysterol binding protein. Yeast. 1994;10:341-353.
27. Lehto M, Laitinen S, Chinetti G, et al. The OSBP-related protein family in humans. J Lipid Res. 2001;42:1203-1213.
28. Venkateswaran A, Laffitte BA, Joseph SB, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A. 2000;97:12097-12102.
29. Whitney KD, Watson MA, Goodwin B, et al. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. J Biol Chem. 2001;276:43509-43515.
30. Moreira EF, Larrayoz IM, Lee JW, Rodriguez IR. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Invest Ophthalmo Vis Sci. 2009;50:523-532.
31. Johansson M, Bocher V, Lehto M, et al. The two variants of oxysterol binding protein-related protein-1 display different tissue expression patterns, have different intracellular localization, and are functionally distinct. Mol Biol Cell. 2003:14:903-915.
32. Balla A, Tuymetova G, Tsiomenko A, Varnai P, Balla T. A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. Mol Biol Cell. 200:16:1282-1295.
33. Wyles JP, Ridgway ND. VAMP-associated protein-A regulates partitioning of oxysterol-binding protein-related protein-9 between the endoplasmic reticulum and Golgi apparatus. Exp Cell Res. 2004;297:533-547.
34. Ngo M, Ridgway ND. Oxysterol binding protein (OSBP)-related Protein 9 (ORP9) is a cholesterol transfer protein that regulates Golgi structure and function. Mol Biol Cell. 2009;20:1388-1399.
35. Im YJ, Raychaudhuri S, Prinz WA, Hurley JH. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature. 2005;437:154-158.
36. Wang PY, Weng J, Anderson RG. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science. 2005; 307:1472-1476.
37. Lessmann E, Ngo M, Leitges M, Minguet S, Ridgway ND, Huber M. Oxysterol-binding protein-related protein (ORP) 9 is a PDK-2 substrate and regulates Akt phosphorylation. Cell Signal. 2007;19:384-392.
38. Park BC, Shen X, Samaraweera M, Yue BY. Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol. 2006;169:1976-1989.
39. Malyukova I, Lee HS, Fariss RN, Tomarev SI. Mutated mouse and human myocilins have similar properties and do not block general secretory pathway. Invest Ophthalmol Vis Sci. 2006;47:206-212.
40. Ahn AH, Kunkel LM. Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol. 1995;128:363-371.
41. Schultz J, Hoffmuller U, Krause G, et al. Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat Struct Biol. 1998;5:19-24.
42. Gee SH, Madhavan R, Levinson SR, Caldwell JH, Sealock R, Froehner SC. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci. 1998;18:128-137.
43. Brenman JE, Chao DS, Gee SH, et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1- syntrophin mediated by PDZ domains. Cell. 1996;84:757-767.
44. Chamberlain JS, Corrado K, Rafael JA, Cox GA, Hauser M, Lumeng C. Interactions between dystrophin and the sarcolemma membrane. Soc Gen Physiol Ser. 1997;52:19-29.
45. Miyagoe-Suzuki Y, Takeda, S.I. Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma. Microsc Res Technol. 2001;55:164-170.
46. Peters MF, Kramarcy NR, Sealock R, Froehner SC. Beta 2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport. 1994;5:1577-1580.
47. Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci. 1999;2:611-617.
48. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci U S A 2001;98:14108-14113.
49. Noel G, Belda M, Guadagno E, Micoud J, Klocker N, Moukhles H. Dystroglycan and Kir4.1 coclustering in retinal Muller glia is regulated by laminin-1 and requires the PDZ-ligand domain of Kir4.1. J Neurochem. 2005;94:691-702.
50. Connors NC, Kofuji P. Potassium channel Kir4.1 macromolecular complex in retinal glial cells. Glia. 2006;53:124-131.
51. Puwarawuttipanit W, Bragg AD, Frydenlund DS, et al. Differential effect of alpha-syntrophin knockout on aquaporin-4 and Kir4.1 expression in retinal macroglial cells in mice. Neuroscience. 2006; 137:165-175.
52. Rurak J, Noel G, Lui L, Joshi B, Moukhles H. Distribution of potassium ion and water permeable channels at perivascular glia in brain and retina of the Large(myd) mouse. J Neurochem. 2007; 103:1940-1953.
53. Breakthrough of the year: the runners-up. Science. 2008;322:1768.
54. Nork TM, Ver Hoeve JN, Poulsen GL, et al. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol. 2000;118:235-245.
55. Pelzel HR, Schlamp CL, Poulsen GL, Ver Hoeve JA, Nork TM, Nickells RW. Decrease of cone opsin mRNA in experimental ocular hypertension. Mol Vis. 2006;12:1272-1282.
56. Stasi K, Nagel D, Yang X, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci. 2006;47:1024-1029.
57. Wax MB, Tezel G, Yang J, et al. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci. 2008; 28:12085-12096.
58. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1437-1446.
59. Surgucheva I, McMahan B, Ahmed F, Tomarev S, Wax MB, Surguchov A. Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J Neurosci Res. 2002;68:97-106.
60. Huang W, Fileta J, Guo Y, Grosskreutz, CL. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr Eye Res. 2006;31:265-271.
61. Feng L, Rigatti BW, Novak EK, Gorin MB, Swank RT. Genomic structure of the mouse Ap3b1 gene in normal and pearl mice. Genomics. 2000;69:370-379.
62. Feng L, Seymour AB, Jiang S, et al. The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet. 1999;8:323-330.